Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Takeda Pharmaceutical has the lowest figure of the 61 pharmaceutical companies ranked by short interest, at 0.10%, followed by AstraZeneca (0.20%) and Novartis (0.24%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Takeda Pharmaceutical0.10%
- Median
- 5.47%
- Combined market value
- SAR 19.1T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Takeda PharmaceuticalTAK · Health Care | 0.10% | SAR 256.4B | SAR 80.25 | 1.13% down | 54% up | ||
| 2 | AstraZenecaAZN · Health Care | 0.20% | SAR 1.05T | SAR 674.09 | 1.40% down | 2% up | ||
| 3 | NovartisNVS · Health Care | 0.24% | SAR 1.11T | SAR 585.31 | 1.94% down | 25% up | ||
| 4 | SanofiSNY · Health Care | 0.51% | SAR 426.4B | SAR 177.59 | 0.39% down | 4% down | ||
| 5 | Johnson & JohnsonJNJ · Health Care | 0.71% | SAR 2.49T | SAR 1,033.14 | 1.17% down | 38% up | ||
| 6 | GSKGSK · Health Care | 0.81% | SAR 367.1B | SAR 183.12 | 0.85% down | 6% up | ||
| 7 | Eli LillyLLY · Health Care | 0.81% | SAR 4.66T | SAR 5,236.02 | 1.39% down | 35% up | ||
| 8 | Novo NordiskNVO · Health Care | 0.87% | SAR 655.2B | SAR 148.67 | 2.62% down | 17% down | ||
| 9 | GrifolsGRFS · Health Care | 0.88% | SAR 21.6B | SAR 31.75 | 1.91% down | 1% up | ||
| 10 | AbbVieABBV · Health Care | 0.89% | SAR 1.91T | SAR 1,078.98 | 1.77% down | 26% up | ||
| 11 | Merck & CoMRK · Health Care | 1.08% | SAR 1.28T | SAR 519.40 | 3.42% down | 51% up | ||
| 12 | Abbott LaboratoriesABT · Health Care | 1.10% | SAR 679B | SAR 392.02 | 0.19% down | 17% down | ||
| 13 | BeOne MedicinesONC · Health Care | 1.40% | SAR 173.6B | SAR 1,520.17 | 1.93% down | 17% up | ||
| 14 | GenmabGMAB · Health Care | 1.57% | SAR 119.1B | SAR 193.23 | 0.86% down | 70% up | ||
| 15 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | SAR 512.6B | SAR 2,021.83 | 0.90% up | 27% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | SAR 367.9B | SAR 3,556.40 | 1.01% down | 36% up | ||
| 17 | Royalty PharmaRPRX · Health Care | 2.27% | SAR 149.7B | SAR 260.38 | 1.07% up | 78% up | ||
| 18 | Bristol-Myers SquibbBMY · Health Care | 2.29% | SAR 461.6B | SAR 225.81 | 1.87% down | 34% up | ||
| 19 | PfizerPFE · Health Care | 2.36% | SAR 602.8B | SAR 105.76 | 0.97% down | 14% up | ||
| 20 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | SAR 184.5B | SAR 158.16 | 1.07% down | 74% up | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | SAR 47.1B | SAR 56.45 | 1.75% up | 5% up | ||
| 22 | ViatrisVTRS · Health Care | 3.07% | SAR 88.9B | SAR 77.51 | 1.05% up | 96% up | ||
| 23 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | SAR 28.9B | SAR 82.88 | 4.62% up | 83% up | ||
| 24 | Belite BioBLTE · Health Care | 3.40% | SAR 24B | SAR 591.27 | 0.06% down | 31% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | SAR 75.9B | SAR 566.48 | 3.50% down | 66% down | ||
| 26 | ZoetisZTS · Health Care | 4.12% | SAR 129.8B | SAR 319.38 | 1.99% up | 29% down | ||
| 27 | United TherapeuticsUTHR · Health Care | 4.31% | SAR 93.1B | SAR 2,186.57 | 0.20% down | 23% up | ||
| 28 | Ascendis PharmaASND · Health Care | 4.57% | SAR 66.9B | SAR 1,019.78 | 0.25% up | 28% up | ||
| 29 | ABIVAXABVX · Health Care | 4.70% | SAR 27.6B | SAR 315.08 | 2.31% up | 27% down | ||
| 30 | Summit TherapeuticsSMMT · Health Care | 5.28% | SAR 31.6B | SAR 39.48 | 1.36% down | 36% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | SAR 28.1B | SAR 357.58 | 0.23% up | 126% up | ||
| 32 | Legend BiotechLEGN · Health Care | 6.13% | SAR 11.8B | SAR 60.92 | 0.81% up | 42% down | ||
| 33 | Axsome TherapeuticsAXSM · Health Care | 6.20% | SAR 26.6B | SAR 505.03 | 0.96% down | 7% down | ||
| 34 | Roivant SciencesROIV · Health Care | 6.28% | SAR 104.8B | SAR 144.64 | 0.39% down | 90% up | ||
| 35 | InsmedINSM · Health Care | 6.42% | SAR 99.3B | SAR 452.71 | 0.96% down | 40% down | ||
| 36 | Elanco Animal HealthELAN · Health Care | 6.59% | SAR 50.6B | SAR 101.16 | 4.33% up | 20% up | ||
| 37 | Definium TherapeuticsDFTX · Health Care | 7.02% | SAR 14.9B | SAR 108.54 | 1.51% down | 169% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | SAR 44B | SAR 227.23 | 3.53% up | 11% up | ||
| 39 | VeradermicsMANE · Health Care | 8.03% | SAR 19.7B | SAR 467.67 | 0.76% down | 233% up | ||
| 40 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | SAR 23.1B | SAR 163.09 | 1.14% up | 10% up | ||
| 41 | Corcept TherapeuticsCORT · Health Care | 8.34% | SAR 28B | SAR 256.16 | 2.54% down | 8% down | ||
| 42 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | SAR 59.5B | SAR 926.81 | 2.65% up | 37% up | ||
| 43 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | SAR 35.6B | SAR 1,530.88 | 3.29% down | 24% down | ||
| 44 | PTC TherapeuticsPTCT · Health Care | 9.31% | SAR 18.9B | SAR 226.49 | 0.03% up | 20% down | ||
| 45 | Oruka TherapeuticsORKA · Health Care | 9.53% | SAR 24.5B | SAR 360.88 | 0.11% down | 241% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | 9.96% | SAR 18.4B | SAR 192.05 | 0.20% up | 44% up | ||
| 47 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | SAR 22.6B | SAR 346.69 | 0.52% up | 31% up | ||
| 48 | Cogent BiosciencesCOGT · Health Care | 10.0% | SAR 18.4B | SAR 105.82 | 1.29% up | 20% down | ||
| 49 | ErascaERAS · Health Care | 10.6% | SAR 17.8B | SAR 50.71 | 2.66% down | 403% up | ||
| 50 | BridgeBio PharmaBBIO · Health Care | 10.7% | SAR 57.1B | SAR 293.22 | 1.78% up | 17% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | SAR 17.2B | SAR 156.75 | 0.59% down | 88% up | ||
| 52 | AlkermesALKS · Health Care | 11.7% | SAR 29.6B | SAR 176.22 | 3.37% up | 58% up | ||
| 53 | Spyre TherapeuticsSYRE · Health Care | 12.2% | SAR 34.5B | SAR 363.51 | 3.30% up | 286% up | ||
| 54 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | SAR 22.6B | SAR 1,128.39 | 2.39% up | 43% up | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | SAR 17.4B | SAR 104.48 | 3.32% up | 64% down | ||
| 56 | CytokineticsCYTK · Health Care | 12.9% | SAR 27B | SAR 193.81 | 0.04% up | 20% down | ||
| 57 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | SAR 32.4B | SAR 1,158.50 | 1.24% up | 61% up | ||
| 58 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | SAR 30.9B | SAR 472.85 | 1.11% up | 46% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | SAR 18.5B | SAR 327.91 | 0.51% up | 113% up | ||
| 60 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | SAR 31.2B | SAR 450.50 | 2.99% up | 13% up | ||
| 61 | TG TherapeuticsTGTX · Health Care | 19.0% | SAR 37.5B | SAR 247.88 | 5.38% up | 107% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).
Questions and answers
Which pharmaceutical companies have the lowest short interest?
Takeda Pharmaceutical (0.10%), AstraZeneca (0.20%) and Novartis (0.24%) have the lowest short interest of the 61 pharmaceutical companies ranked here as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of SAR 19.1T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.